D. E. Shaw & Co. Inc. Buys Shares of 137,202 BrightSpring Health Services, Inc. (NASDAQ:BTSG)

D. E. Shaw & Co. Inc. purchased a new stake in BrightSpring Health Services, Inc. (NASDAQ:BTSG - Free Report) during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm purchased 137,202 shares of the company's stock, valued at approximately $2,337,000. D. E. Shaw & Co. Inc. owned approximately 0.08% of BrightSpring Health Services as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also bought and sold shares of the stock. Rhumbline Advisers boosted its position in BrightSpring Health Services by 1.5% during the 4th quarter. Rhumbline Advisers now owns 73,583 shares of the company's stock valued at $1,253,000 after buying an additional 1,118 shares during the period. MetLife Investment Management LLC boosted its stake in shares of BrightSpring Health Services by 4.9% during the 4th quarter. MetLife Investment Management LLC now owns 33,117 shares of the company's stock valued at $564,000 after purchasing an additional 1,548 shares in the last quarter. Quarry LP bought a new position in BrightSpring Health Services in the fourth quarter worth about $29,000. Legal & General Group Plc grew its holdings in shares of BrightSpring Health Services by 4.8% during the 4th quarter. Legal & General Group Plc now owns 64,631 shares of the company's stock worth $1,101,000 after acquiring an additional 2,945 shares during the period. Finally, R Squared Ltd purchased a new position in shares of BrightSpring Health Services in the 4th quarter valued at approximately $74,000.

Analyst Ratings Changes

BTSG has been the subject of several recent analyst reports. UBS Group lifted their price target on BrightSpring Health Services from $22.00 to $30.00 and gave the stock a "buy" rating in a research report on Wednesday, January 29th. Wells Fargo & Company boosted their price objective on shares of BrightSpring Health Services from $25.00 to $27.00 and gave the stock an "overweight" rating in a report on Tuesday, May 13th. Morgan Stanley upped their target price on shares of BrightSpring Health Services from $20.00 to $25.00 and gave the company an "overweight" rating in a research note on Friday, May 9th. Finally, Mizuho set a $26.00 target price on BrightSpring Health Services in a report on Monday, May 5th. One equities research analyst has rated the stock with a hold rating and nine have issued a buy rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and an average target price of $23.56.

BrightSpring Health Services Price Performance

Shares of BTSG stock traded up $0.31 during mid-day trading on Monday, hitting $23.23. 1,101,221 shares of the stock were exchanged, compared to its average volume of 1,431,291. The company has a quick ratio of 0.97, a current ratio of 1.35 and a debt-to-equity ratio of 1.63. BrightSpring Health Services, Inc. has a 52-week low of $10.15 and a 52-week high of $24.82. The firm has a fifty day moving average of $19.30 and a 200 day moving average of $19.25. The company has a market cap of $4.05 billion, a PE ratio of -89.35 and a beta of 2.06.

BrightSpring Health Services (NASDAQ:BTSG - Get Free Report) last released its earnings results on Friday, May 2nd. The company reported $0.19 earnings per share for the quarter, beating the consensus estimate of $0.09 by $0.10. The business had revenue of $2.88 billion for the quarter, compared to the consensus estimate of $2.74 billion. BrightSpring Health Services had a positive return on equity of 4.16% and a negative net margin of 0.38%. The business's quarterly revenue was up 25.9% compared to the same quarter last year. During the same quarter last year, the business posted $0.12 earnings per share. Research analysts anticipate that BrightSpring Health Services, Inc. will post 0.59 earnings per share for the current year.

About BrightSpring Health Services

BrightSpring Health Services, Inc operates a home and community-based healthcare services platform in the United States. The company's platform focuses on delivering pharmacy and provider services, including clinical and supportive care in home and community settings to Medicare, Medicaid, and insured populations.